Medimi AB (Publ)
Climate Impact & Sustainability Data (2020, 2021)
Reporting Period: 2020
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Not disclosed
Environmental Achievements
- Not disclosed
Social Achievements
- Increased medication adherence to over 99% for users, significantly reducing home healthcare visits and medication waste. Improved patient satisfaction and independence.
Governance Achievements
- Not disclosed
Climate Goals & Targets
Long-term Goals:
- Introduce Medimi®Smart to the North American market. Achieve approximately SEK 100 million in annual net sales and a gross margin exceeding 60% within five years.
Medium-term Goals:
- Establish a strong position in the Nordic region and begin expansion into selected European markets. Register Medimi®Smart for the North American market.
Short-term Goals:
- Establish market share in the Nordic region (excluding Finland).
Environmental Challenges
- Lower than expected sales due to the COVID-19 pandemic.
- Competition from solutions based on blister packs.
- Time-consuming public procurement processes.
Mitigation Strategies
- Strengthened marketing efforts to increase brand awareness and participation in public tenders.
- Established commercial and operational partnerships in Norway (Hepro A/S) and Denmark (ATEA Danmark) to expand market reach.
- Successfully completed a 370% oversubscribed rights issue to secure funding for future growth.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- TIM project won the audience award at the annual digitalization prize in Denmark.
Reporting Period: 2021
Environmental Metrics
Social Achievements
- Improved medication adherence to over 99% in Aalborg, compared to a global average of around 50%, resulting in increased patient safety and independence. 95% of users surveyed would recommend the solution.
Climate Goals & Targets
Long-term Goals:
- Introduce the solution to the North American market.
Medium-term Goals:
- Establish a position in all of the Nordic countries and begin establishment in selected markets in Europe.
- Register Medimi®Smart for the North American market.
Short-term Goals:
- Establish market share in the Nordic countries.
Environmental Challenges
- Slow market development in Sweden due to the strong position of dose packs.
- Slower than hoped-for development in the Norwegian market due to the impact of Omicron.
- Pandemic impact on installation rate and sales meetings.
- High cost of appealing procurement decisions in Sweden.
Mitigation Strategies
- Continued work on appealing procurement decisions (though unsuccessful in 2021).
- Increased marketing and sales efforts to engage earlier in the dialogue with municipalities.
- Partnership with Apoteksgruppen in Sweden.
- Close collaboration with Hepro in Norway for marketing and integration.
- Improvements to solution quality and cost of support and maintenance to increase installations with existing cost mass.